- Home
- products
- switzerland
- subcutaneous injection
Show results for
Refine by
Subcutaneous Injection Equipment Supplied In Switzerland
5 equipment items found
Manufactured by:BÜHLMANN Laboratories AG based inSchönenbuch, SWITZERLAND
The rise of anti TNFα biologics has been a significant step forward to ameliorating disease course and keep inflammations at remission levels for prolonged periods of time. Adalimumab is the first anti TNFα biologic on the market approved for patient self-administration by subcutaneous injections. Patients with suboptimal drug concentrations have ...
Manufactured by:SHL Medical AG based inZug, SWITZERLAND
Inheriting the classic Molly’s compact design and simplicity of use, this second-generation Molly autoinjector is designed with a new ergonomic body and a flange-shaped anti-roll cap for an easier handling experience. Built on a modular platform technology, Molly is designed to meet the evolving requirements of future autoinjectors, such as introducing unique designs for branding and user ...
Manufactured by:SHL Medical AG based inZug, SWITZERLAND
The first DAI was built for a multinational biopharmaceutical company headquartered in the US. It is a button-activated, 3-step disposable device for 1 mL pre-filled syringes. We were tasked to design an injection device that could facilitate an easier subcutaneous self-injection experience compared to the alternative pre-filled syringe or vial. ...
Manufactured by:BÜHLMANN Laboratories AG based inSchönenbuch, SWITZERLAND
The Quantum Blue® Adalimumab assay measures from 1.3 to 35 µg/ml. The target concentrations for the optimal therapeutic window lies well within the linear range of the test. Quantum Blue® Adalimumab provides a quantitative result within 15 minutes of incubation time. This offers the possibility to health care providers to act immediately while following up the patient’s ...
Manufactured by:Alnylam Pharmaceuticals, Inc. based inCambridge, MASSACHUSETTS (USA)
GIVLAARI® (givosiran) is a prescription medicine used to treat acute hepatic porphyria (AHP) in ...